MELBOURNE, Australia and SAN FRANCISCO, May 07, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today announced that multiple oral and poster presentations related to Alterity's clinical programs in Multiple System Atrophy (MSA) will be featured at the 2025 International MSA Congress taking place May 9 - 11, 2025 in Boston, MA, USA. The Congress is presented by Mission MSA, a non-profit organization dedicated to improving the quality of life and building hope for people affected by MSA through support services, educational …

The market has been treading through rough waters in 2025, but several stocks in the entertainment industry are among the stars shining the brightest despite this. While many sectors have struggled to gain traction amid economic uncertainty and mixed earnings results, a select group of entertainment names has managed to stand out.

Energizer's fiscal second-quarter net sales and earnings decline year over year. The company lowers its fiscal 2025 guidance amid ongoing macroeconomic headwinds.

Yes, Consumer Staples are boring but nothing is boring about making money.

Ares Commercial Real Estate (ACRE) came out with quarterly earnings of $0.13 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.62 per share a year ago.

Entegris (ENTG) came out with quarterly earnings of $0.67 per share, missing the Zacks Consensus Estimate of $0.69 per share. This compares to earnings of $0.68 per share a year ago.

National Vision (EYE) came out with quarterly earnings of $0.34 per share, beating the Zacks Consensus Estimate of $0.29 per share. This compares to earnings of $0.30 per share a year ago.

Acushnet (GOLF) came out with quarterly earnings of $1.62 per share, beating the Zacks Consensus Estimate of $1.32 per share. This compares to earnings of $1.43 per share a year ago.

LivaNova (LIVN) came out with quarterly earnings of $0.88 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.73 per share a year ago.

Axalta Coating Systems (AXTA) came out with quarterly earnings of $0.59 per share, beating the Zacks Consensus Estimate of $0.54 per share. This compares to earnings of $0.48 per share a year ago.

Radware (RDWR) came out with quarterly earnings of $0.27 per share, beating the Zacks Consensus Estimate of $0.23 per share. This compares to earnings of $0.16 per share a year ago.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of GoHealth, Inc. ("GoHealth, Inc.") (NASDAQ:GOCO) concerning possible violations of federal securities laws. The U.S. Department of Justice ("DOJ") announced on May 1, 2025, the filing of a False Claims Act complaint against several health insurance companies and insurance broker organizations, including GoHealth, "alleging that from 2016 through at least 2021, the defendant insurers paid hundreds of millions of dollars in illegal kickbacks to the defendant brokers in exchange for enrollments into the insurers' Medicare Advantage plans.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Ibotta, Inc. (NYSE:IBTA) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ibotta-lawsuit-submission-form?prid=147264&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Actinium Pharmaceuticals, Inc. (NYSE:ATNM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/actinium-lawsuit-submission-form?prid=147265&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Zenas BioPharma, Inc. (NASDAQ:ZBIO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/zenas-biopharma-inc-lawsuit-submission-form?prid=147266&wire=1 or contact Joseph E. Levi, Esq.

HORSHAM, Pa., May 07, 2025 (GLOBE NEWSWIRE) -- STRATA Skin Sciences, Inc. (“STRATA” or the “Company”) (NASDAQ: SSKN), a medical technology company dedicated to developing, commercializing, and marketing innovative products for the treatment of dermatologic conditions, announces that it will report first quarter 2025 financial results on Wednesday, May 14, 2025 after the market close.

OMAHA, Neb., May 07, 2025 (GLOBE NEWSWIRE) -- On May 7, 2025, Greystone Housing Impact Investors LP (NYSE: GHI) (the “Partnership”) announced financial results for the three months ended March 31, 2025.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Wabash National Corporation ("Wabash National") (NYSE:WNC) concerning possible violations of federal securities laws. On April 30, 2025, Wabash issued a press release announcing its financial results for Q1 of 2025.

Netflix announced on Wednesday that it's currently testing a short-form video feature, signaling that even a streaming giant with over 300 million subscribers is concerned about losing viewers' time spent on mobile to apps like TikTok, YouTube Shorts, and Instagram Reels.

NEW YORK, NY / ACCESS Newswire / May 7, 2025 / If you suffered a loss on your Open Lending Corporation (NASDAQ:LPRO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/open-lending-corporation-lawsuit-submission-form?prid=147268&wire=1 or contact Joseph E. Levi, Esq.